A study on PUFAs and foetal neurodevelopment

ID61
NameA study on PUFAs and foetal neurodevelopment

Biomarker measurements

Biomarker concentration values

IDParent IDDepthSubject groupPopulationCountryCountry codeCohortTime definitionBiospecimenAnalytical methodBiomarkerBiomarker detailMeasurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianAdjustment typeAdjusted onRegressed onExpressed asPublication
5633102351AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FIDMyristic acid (14:0)350.5290.1730.250.94percentRoot0.5 percentRootCrudeParra 2002
5634102351AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FIDPalmitic acid (16:0)3521.3822.4912.91524.874percentRoot21.4 percentRootCrudeParra 2002
5635102351AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FIDPalmitoleic acid (cis-16:1n-7)350.910.242586.01.459percentRoot0.9 percentRootCrudeParra 2002
5636102351AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FIDStearic acid (18:0)3516.17710.4513.93518.389percentRoot16.2 percentRootCrudeParra 2002
563756392AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FIDOleic acid (cis-18:1n-9)3517.8371.44214.05421.628percentRoot17.8 percentRootCrudeParra 2002
563856392AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FID11-Eicosenoic acid (cis-20:1n-9)350.9970.3520.5431.874percentRoot1.0 percentRootCrudeParra 2002
5639102351AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FIDFatty acids, n9-monounsaturated (n9-MUFA)11-Eicosenoic acid (cis-20:1n-9)
Oleic acid (cis-18:1n-9)
3518.8341.7314.69723.502percentRoot18.8 percentRootCrudeParra 2002
564056462AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FIDLinoleic acid (LA; cis-18:2n-6)3512.611.26810.50615.194percentRoot12.6 percentRootCrudeParra 2002
564156462AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FIDgamma-Linolenic acid (GLA; cis-18:3n-6)340.1630.0760.0720.354percentRoot0.2 percentRootCrudeParra 2002
564256462AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FIDEicosadienoic acid (cis-20:2n-6)351.6270.620.653.091percentRoot1.6 percentRootCrudeParra 2002
564356462AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FIDDihomo-gamma-linolenic acid (DGLA; cis-20:3n-6)351.7540.5570.6753.091percentRoot1.8 percentRootCrudeParra 2002
564456462AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FIDArachidonic acid (AA; cis-20:4n-6)359.692.2994.58814.702percentRoot9.7 percentRootCrudeParra 2002
564556462AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FIDDocosatetraenoic acid (DTA; cis-22:4n-6)352.9530.7561.5814.406percentRoot3.0 percentRootCrudeParra 2002
5646102351AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FIDFatty acids, n6-polyunsaturated (n6-PUFA)Arachidonic acid (AA; cis-20:4n-6)
Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6)
Docosatetraenoic acid (DTA; cis-22:4n-6)
Eicosadienoic acid (cis-20:2n-6)
Linoleic acid (LA; cis-18:2n-6)
gamma-Linolenic acid (GLA; cis-18:3n-6)
3428.6132.91422.83134.21percentRoot28.6 percentRootCrudeParra 2002
564756522AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FIDalpha-Linolenic acid (ALA; cis-18:3n-3)351.8511.0680.2974.458percentRoot1.9 percentRootCrudeParra 2002
564856522AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FIDEPA (cis-20:5n-3)351.3040.1840.9911.82percentRoot1.3 percentRootCrudeParra 2002
564956522AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FIDEicosatrienoic acid (ETE; cis-20:3n-3)340.3550.0950.1460.577percentRoot0.4 percentRootCrudeParra 2002
565056522AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FIDDPA (cis-22:5n-3)353.7210.6351.0664.465percentRoot3.7 percentRootCrudeParra 2002
565156522AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FIDDHA (cis-22:6n-3)356.0590.8524.8428.085percentRoot6.1 percentRootCrudeParra 2002
5652102351AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentRed blood cell membrane, unspecifiedGC-FIDFatty acids, n3-polyunsaturated (n3-PUFA)DHA (cis-22:6n-3)
DPA (cis-22:5n-3)
EPA (cis-20:5n-3)
Eicosatrienoic acid (ETE; cis-20:3n-3)
alpha-Linolenic acid (ALA; cis-18:3n-3)
3413.2591.4210.02417.344percentRoot13.3 percentRootCrudeParra 2002

Intake values

IDParent IDDepthSubject groupPopulationCountryCountry codeCohortTime definitionIntake toolIntake food coverageIntake time coverageIntake assessmentCompoundCompound detailSupplement intakes included?Measurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianAdjustment typeAdjusted onRegressed onExpressed asPublication
5609102361AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)Butyric acid (4:0)1460.5830.270.061.44mg/day0.6 mg/dayCrudeParra 2002
5610102361AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)Caproic acid (6:0)1460.3530.170.040.85mg/day0.4 mg/dayCrudeParra 2002
5611102361AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)Caprylic acid (8:0)1460.2040.10.030.52mg/day0.2 mg/dayCrudeParra 2002
5612102361AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)Capric acid (10:0)1460.5050.220.071.2mg/day0.5 mg/dayCrudeParra 2002
5613102361AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)Lauric acid (12:0)1460.6170.280.071.65mg/day0.6 mg/dayCrudeParra 2002
5614102361AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)Myristic acid (14:0)1462.4520.940.365.42mg/day2.5 mg/dayCrudeParra 2002
5615102361AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)Palmitic acid (16:0)14614.9895.123.3533.71mg/day15.0 mg/dayCrudeParra 2002
5616102361AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)Stearic acid (18:0)1466.5762.451.1615.84mg/day6.6 mg/dayCrudeParra 2002
5617102372AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)cis-Hexadecenoic acids (cis-16:1)1461.6970.620.354.64mg/day1.7 mg/dayCrudeParra 2002
5618102372AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)cis-Octadecenoic acids (cis-18:1)Oleic acid (cis-18:1n-9)
14626.40310.095.5864.96mg/day26.4 mg/dayCrudeParra 2002
561956183AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)Oleic acid (cis-18:1n-9)14617.8957.563.5649.46mg/day17.9 mg/dayCrudeParra 2002
5620102372AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)Elaidic acid (trans-18:1n-9)1461.4350.850.17.85mg/day1.4 mg/dayCrudeParra 2002
5621102372AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)cis-Eicosenoic acids (cis-20:1)1460.1370.070.020.41mg/day0.1 mg/dayCrudeParra 2002
5622102372AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)cis-Docosenoic acids (cis-22:1)1460.0220.030.00.13mg/day0.0 mg/dayCrudeParra 2002
5623102382AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)6Z,9Z-Octadecadienoic acid (cis-18:2n-9)14610.3945.032.8232.3mg/day10.4 mg/dayCrudeParra 2002
5624102382AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)6E,9E-Octadecadienoic acid (trans-18:2n-9)1460.1580.090.00.88mg/day0.2 mg/dayCrudeParra 2002
5625102382AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)6Z,9E-Octadecadienoic acid (cis,trans-18:2n-9)1460.320.250.02.3mg/day0.3 mg/dayCrudeParra 2002
5626102382AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)Linoleic acid (LA; cis-18:2n-6)14614.7958.924.0543.04mg/day14.8 mg/dayCrudeParra 2002
5627102382AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)Arachidonic acid (AA; cis-20:4n-6)1460.170.080.010.39mg/day0.2 mg/dayCrudeParra 2002
5628102382AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)Osbond acid (cis-22:5n-6)1460.0050.010.00.03mg/day0.0 mg/dayCrudeParra 2002
5629102382AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)alpha-Linolenic acid (ALA; cis-18:3n-3)1461.5180.710.35.86mg/day1.5 mg/dayCrudeParra 2002
5630102382AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)Stearidonic acid (cis-18:4n-3)1460.0070.010.00.06mg/day0.0 mg/dayCrudeParra 2002
5631102382AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)EPA (cis-20:5n-3)1460.0520.040.00.26mg/day0.1 mg/dayCrudeParra 2002
5632102382AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)DHA (cis-22:6n-3)1460.140.110.00.63mg/day0.1 mg/dayCrudeParra 2002
102360AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)Fats6E,9E-Octadecadienoic acid (trans-18:2n-9)
6Z,9E-Octadecadienoic acid (cis,trans-18:2n-9)
6Z,9Z-Octadecadienoic acid (cis-18:2n-9)
Arachidonic acid (AA; cis-20:4n-6)
Butyric acid (4:0)
Capric acid (10:0)
Caproic acid (6:0)
Caprylic acid (8:0)
DHA (cis-22:6n-3)
EPA (cis-20:5n-3)
Elaidic acid (trans-18:1n-9)
Lauric acid (12:0)
Linoleic acid (LA; cis-18:2n-6)
Myristic acid (14:0)
Oleic acid (cis-18:1n-9)
Osbond acid (cis-22:5n-6)
Palmitic acid (16:0)
Stearic acid (18:0)
Stearidonic acid (cis-18:4n-3)
alpha-Linolenic acid (ALA; cis-18:3n-3)
cis-Docosenoic acids (cis-22:1)
cis-Eicosenoic acids (cis-20:1)
cis-Hexadecenoic acids (cis-16:1)
146103.4331.9926.31204.53mg/day103.4 mg/dayCrudeParra 2002
10237102361AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)Fatty acids, monounsaturated (MUFA)Elaidic acid (trans-18:1n-9)
Oleic acid (cis-18:1n-9)
cis-Docosenoic acids (cis-22:1)
cis-Eicosenoic acids (cis-20:1)
cis-Hexadecenoic acids (cis-16:1)
14638.5213.776.987.41mg/day38.5 mg/dayCrudeParra 2002
10238102361AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)Fatty acids, polyunsaturated (PUFA)6E,9E-Octadecadienoic acid (trans-18:2n-9)
6Z,9E-Octadecadienoic acid (cis,trans-18:2n-9)
6Z,9Z-Octadecadienoic acid (cis-18:2n-9)
Arachidonic acid (AA; cis-20:4n-6)
DHA (cis-22:6n-3)
EPA (cis-20:5n-3)
Linoleic acid (LA; cis-18:2n-6)
Osbond acid (cis-22:5n-6)
Stearidonic acid (cis-18:4n-3)
alpha-Linolenic acid (ALA; cis-18:3n-3)
14622.048.965.3150.7mg/day22.0 mg/dayCrudeParra 2002
102390AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)Energy1462898.62770.67862.15165.61kcal/day2898.6 kcal/dayCrudeParra 2002

Correlation values

IDIntake IDExcretion IDSubject groupPopulationCountryCountry codeCohortIntake Time definitionIntake assessmentIntakeIntake detailSupplement intakes included?Intake Arithmetic meanIntake Geometric meanIntake MedianIntake UnitIntake Adjusted onBiomarker Time definitionBiological specimenBiomarker Experimental methodBiomarkerBiomarker detailBiomarker Arithmetic meanBiomarker Geometric meanBiomarker MedianBiomarker UnitBiomarker Adjusted onCorrelation sizeCorrelation typeCorrelation valueCorrelation 95% CI lowerCorrelation 95% CI upperCorrelation p-valueSignificant?Measurement adjustmentDeattenuated?CovariatesPublication
550456295647AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)alpha-Linolenic acid (ALA; cis-18:3n-3)1.518mg/dayRed blood cell membrane, unspecifiedGC-FIDalpha-Linolenic acid (ALA; cis-18:3n-3)1.851percentRoot35Pearson0.32< 0.05YesParra 2002
550556315648AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)EPA (cis-20:5n-3)0.052mg/dayRed blood cell membrane, unspecifiedGC-FIDEPA (cis-20:5n-3)1.304percentRoot35Pearson0.36< 0.05YesParra 2002
550656325651AllPregnant womenMexicoMXA study on PUFAs and foetal neurodevelopmentFood Frequency Questionnaire (FFQ)DHA (cis-22:6n-3)0.14mg/dayRed blood cell membrane, unspecifiedGC-FIDDHA (cis-22:6n-3)6.059percentRoot35Pearson0.35< 0.05YesParra 2002

Reproducibility values

No data available